2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$3.76+$0.08 (+2.17%)
Price as of Jun 23, 2026 5:45 PM EDT- $261.3MMarket Cap
- 172.59%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$3.76+$0.08 (+2.17%)
ZNTL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.68 | ||
Change | +$0.01 (+0.27%) | ||
Open | $3.60 | ||
High | $3.80 | ||
Low | $3.60 | ||
Previous Close | $3.67 | ||
Volume | 674,398 | ||
30-Day Average Volume | 799,867 | ||
1-Week Change | 4.55% | ||
1-Month Change | -9.36% | ||
1-Year Change | 172.59% | ||
3-Year Change | -87.31% | ||
5-Year Change | -92.97% | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $253.1M | ||
Market Cap | $261.3M | ||
Enterprise Value | $229.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$35.4M | ||
Free Cash Flow | -$33.0M | ||
EBIT | -$35.2M | ||
EBITDA | -$35.1M | ||
Net Working Capital | $182.9M | ||
EPS | -$0.50 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 4 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue